- Health & Pharmaceuticals›
- Pharmaceutical Products & Market›
Capital raised by regenerative medicine companies worldwide 2016-2018
Premium statistics
Industry-specific and extensively researched technical data (partially from exclusive partnerships).
A paid subscription is required for full access.
Capital raised by regenerative medicine companies worldwide 2016-2018
Capital raised by regenerative medicine companies worldwide from 2016 to 2018 (in million U.S. dollars)*
by Matej Mikulic,
last edited
Jan 14, 2019
This statistic depicts the capital raised by regenerative medicine companies worldwide from 2016 to 2018, measured in million U.S. dollars. In 2017, the total amount raised by this industry stood at 7.5 billion U.S. dollars.
Capital raised by regenerative medicine companies worldwide from 2016 to 2018 (in million U.S. dollars)*
| 2016 | 2017 | 2018 | |
|---|---|---|---|
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| 2016 | 2017 | 2018 | |
|---|---|---|---|
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
Employee Account
Please create an employee account to be able to mark statistics as favorites.
Then you can access your favorite statistics via the star in the header.
Register now
Exclusive Premium statistic
You need a Premium Account for unlimited access.
Full access to 1m statistics
Incl. source references
Available to download in PNG, PDF, XLS format
Exclusive content
Exclusive Premium statistic
You need a Premium Account for unlimited access.
Full access to 1m statistics
Incl. source references
Available to download in PNG, PDF, XLS format
© Statista 2019
About this statistic
Show source
Download
Settings
Share
Chart type
Datalabels
Share on Social Media
Download started
Please be patient - this may take a moment
Please be patient - this may take a moment
Description
Source
More information
by Matej Mikulic,
last edited
Jan 14, 2019
This statistic depicts the capital raised by regenerative medicine companies worldwide from 2016 to 2018, measured in million U.S. dollars. In 2017, the total amount raised by this industry stood at 7.5 billion U.S. dollars.
- Show sources information
- Show publisher information
- Release date
- 2019
- Region
- Worldwide
- Survey time period
- 2016 to 2018
- Supplementary notes
-
* Note: total amount raised represents sector-wide figures; some companies are active in more than one technology group. Data does not include M&A transactions.
All values are rounded.
This statistic was assembled from several ARM State of the Industry reports.
Source
- Show sources information
- Show publisher information
- Release date
- 2019
More information
- Region
- Worldwide
- Survey time period
- 2016 to 2018
- Supplementary notes
-
* Note: total amount raised represents sector-wide figures; some companies are active in more than one technology group. Data does not include M&A transactions.
All values are rounded.
This statistic was assembled from several ARM State of the Industry reports.
Other statistics on the topic
Biotechnology industry
+Pharmaceutical Products & Market
Global cell and gene therapy market forecast 2012-2020
+Pharmaceutical Products & Market
Global stem cell market size forecast 2025
+Pharmaceutical Products & Market
Regenerative medicine companies by world region 2019
+Health System
View of increasing government funding for stem cell research - U.S. adults 2017
Statista Accounts:
Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account!
Premium Account
Your perfect start with Statista
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$59 / Month *
Corporate Account
Full access
Corporate solution including all features.
* All products require an annual contract.
Prices do not include sales tax.
Prices do not include sales tax.
Leading companies trust Statista:
Related Studies: Available to Download in PDF or PPTX Format
All Information
in one Presentation
Cell and gene therapy
- 72 page/s
- English
- pptx
- Detailed references
Everything On "Cell and gene therapy" in One Document: Edited and Divided into Handy Chapters. Including Detailed References.
Other Reports & Dossiers
I think of Statista as Google for researchers. Statista provides you with the information you search for right away.Dr. Horst Stipp
EVP, Research & Innovation, Advertising Research Foundation
Statistics on "Cell and gene therapy"
- Market overview
The most important statistics
- Projected global market size for regenerative medicine from 2016 to 2025 (in billion euros)Global market size for regenerative medicine from 2016-2025
- Global cell and gene therapy market forecast between 2012 and 2020 (in billion U.S. dollars)Global cell and gene therapy market forecast 2012-2020
- Global cell culture market size from 2012 to 2022 (in million U.S. dollars)Global cell culture market size 2012-2022
- Distribution of advanced therapy medicinal products (ATMP) by classification worldwide as of 2016ATMP classification share worldwide 2016
- Distribution of regenerative medicine companies by world region as of 2019*Regenerative medicine companies by world region 2019
- Market capitalization of selected larger gene and cell therapy companies in the U.S. as of 2017 (in billion U.S. dollars)*Market cap of larger gene and cell therapy companies in U.S. as of 2017
- R&D/trials
The most important statistics
- Classification of advanced therapy medicinal product (ATMP) trials worldwide as of 2016, by disease area and phaseATMP trials classification share by disease and development phase globally 2016
- Distribution of advanced therapy medicinal product (ATMP) clinical trials by type of sponsor worldwide as of 2016ATMP clinical trials share globally by type of sponsor
- Distribution of non-commercial advanced therapy medicinal product (ATMP) trials by sponsor worldwide as of 2016ATMP clinical trials non-commercial sponsors distribution globally 2016
- Number of stem-cell and gene therapies in current development as of 2017, by developerNumber of biotech therapies in development as of 2017, by developer
- Percentage of stem-cell and gene therapies in current development as of 2017, by developerPercentage of biotech therapies in development as of 2017, by developer
- Stem cells
The most important statistics
- Global stem cell market size by world region between 2011 and 2016 (in billion U.S. dollars)*Global stem cell market size by world region 2011-2016
- Distribution of the stem cell technologies and applications market by world region in 2016Stem cell technologies and applications market share by world region 2016
- Global stem cell market size in 2016 and a forecast for 2025 (in billion U.S. dollars)*Global stem cell market size forecast 2025
- Number of hematopoietic stem cell (HSC) transplants in the United States from 2010 to 2015, by sourceNumber of HSC transplants in the US from 2010-2015, by source
- Total stem cell research funding by the National Institutes for Health (NIH) from FY 2013 to FY 2018 (in million U.S. dollars)Total stem cell research funding by the National Institutes for Health 2013-2018
- Cord blood
The most important statistics
- Aggregate annual demand of cord blood units (CBUs) in the U.S. from 2010 to 2016*Aggregate annual demand for cord blood units from 2010-2016
- Average annual social value of the U.S. cord blood bank system based on donor/patient matching from 2010 to 2016 (in million U.S. dollars) Annual social value of U.S. CBB system by scenario 2010-2016
- Percentage of cord blood units (CBUs) from the U.S. shipped to domestic and international destinations from 2010 to 2016Percentage of CBUs from the U.S. shipped domestically and internationally 2010-2016
- Share of U.S. cord blood units (CBUs) shipped by the U.S. by total nucleated cell count (TNC) from 2002 to 2016Percentage of shipped U.S. cord blood units by TNC count 2002-2016
- Share of U.S. cord blood units (CBUs) stored by total nucleated cell count (TNC) from 2002 to 2016Percentage of stored U.S. CBUs by TNC count 2002-2016
- CAR/CAR-T
The most important statistics
- Number of CAR cell therapy trials worldwide from 2007 to 2016*Number of CAR cell therapy trials worldwide 2007-2016
- Number of CAR cell therapy trials, comparing the U.S. and China from 2009 to 2016*Number of CAR cell therapy trials U.S. vs China 2009-2016
- Venture capital funding for select companies involved in CAR-T programs between 2011 and 2016 (in million U.S. dollars)*Venture capital funding for companies in CAR-T programs 2011-2016
- Selected IPOs of companies with a CAR-T focus between 2013 and 2015 (in million U.S. dollars)*IPO value of select CAR-T companies 2013-2015
- Miscellaneous
The most important statistics
- Average length of stay for an inpatient hematopoietic stem cell (HSC) transplant in the United States in 2014, by procedureLength of hospital stay for an HSC transplant in the U.S. in 2014, by procedure
- Hospital charges and costs for an inpatient hematopoietic stem cell (HSC) transplant under Medicaid in 2014, by procedure (in U.S. dollars)Medicaid charges and costs for an HSC transplant in the U.S. in 2014, by procedure
- Capital raised by regenerative medicine companies worldwide from 2016 to 2018 (in million U.S. dollars)*Capital raised by regenerative medicine companies worldwide 2016-2018
- Price of select market-stage advanced therapy medicinal products (ATMPs) as of 2016 (in U.S. dollars)Select market-stage ATMPs price in the U.S. as of 2016
- Do you favor or oppose expanding federal funding for research using embryonic stem cells?View of increasing government funding for stem cell research - U.S. adults 2017
Discover Statista
Need help with using Statista for your research?
Tutorials and first steps
Further Content: You might find this interesting as well
Statistics
- Regenerative medicines market share by therapy type forecast 2016 and 2025
- Regenerative medicines market size by therapy type forecast 2016-2025
- Global cell and gene therapy pipeline by phase 2016
- Regenerative medicines market share by application forecast 2016 and 2025
- Regenerative medicines market size forecast 2025
- Global recombinant cell culture supplements market value forecast 2028
- Global recombinant cell culture supplements market share by application 2017 vs. 2028
- Canadian biotech companies - financing data 2010-2012
- Global jet lag therapy market share by 2016 and 2023 by product type
- Orphan drug sales worldwide excluding oncology by therapy category 2024
- Worldwide share of orphan drug sales by therapy category without oncology 2024
- Global jet lag therapy market size by 2016 and 2023
- U.S. spending on therapeutic oncology and supportive care by type 2011-2015
- Total public drug program spending in Canada by therapy 2017
- Eligible men for androgen replacement therapy in the United States 2001-2011
- Investment value in automotive finance industry in China 2013-2018
- Restricted access to finance affecting growth of mid-market companies UK 2015
- Distribution of vehicle loans in the U.S. 2019, by lender type
- Distribution of Taiwan's overseas credit guarantees 2018 by industry
- Provision of green microloans in Romania in 2013
Statistics on "Cell and gene therapy - Market overview"
- Global market size for regenerative medicine from 2016-2025
- Global cell and gene therapy market forecast 2012-2020
- Global cell culture market size 2012-2022
- ATMP classification share worldwide 2016
- Regenerative medicine companies by world region 2019
- Market cap of larger gene and cell therapy companies in U.S. as of 2017
Statistics on "Cell and gene therapy - R&D/trials"
- ATMP trials classification share by disease and development phase globally 2016
- ATMP clinical trials share globally by type of sponsor
- ATMP clinical trials non-commercial sponsors distribution globally 2016
- Number of biotech therapies in development as of 2017, by developer
- Percentage of biotech therapies in development as of 2017, by developer
Statistics on "Cell and gene therapy - Stem cells"
- Global stem cell market size by world region 2011-2016
- Stem cell technologies and applications market share by world region 2016
- Global stem cell market size forecast 2025
- Number of HSC transplants in the US from 2010-2015, by source
- Total stem cell research funding by the National Institutes for Health 2013-2018
Statistics on "Cell and gene therapy - Cord blood"
- Aggregate annual demand for cord blood units from 2010-2016
- Annual social value of U.S. CBB system by scenario 2010-2016
- Percentage of CBUs from the U.S. shipped domestically and internationally 2010-2016
- Percentage of shipped U.S. cord blood units by TNC count 2002-2016
- Percentage of stored U.S. CBUs by TNC count 2002-2016
Statistics on "Cell and gene therapy - CAR/CAR-T"
Statistics on "Cell and gene therapy - Miscellaneous"
- Length of hospital stay for an HSC transplant in the U.S. in 2014, by procedure
- Medicaid charges and costs for an HSC transplant in the U.S. in 2014, by procedure
- Capital raised by regenerative medicine companies worldwide 2016-2018
- Select market-stage ATMPs price in the U.S. as of 2016
- View of increasing government funding for stem cell research - U.S. adults 2017
Further related statistics
- Regenerative medicines market share by therapy type forecast 2016 and 2025
- Regenerative medicines market size by therapy type forecast 2016-2025
- Global cell and gene therapy pipeline by phase 2016
- Regenerative medicines market share by application forecast 2016 and 2025
- Regenerative medicines market size forecast 2025
- Global recombinant cell culture supplements market value forecast 2028
- Global recombinant cell culture supplements market share by application 2017 vs. 2028
- Canadian biotech companies - financing data 2010-2012
- Global jet lag therapy market share by 2016 and 2023 by product type
- Orphan drug sales worldwide excluding oncology by therapy category 2024
- Worldwide share of orphan drug sales by therapy category without oncology 2024
- Global jet lag therapy market size by 2016 and 2023
- U.S. spending on therapeutic oncology and supportive care by type 2011-2015
- Total public drug program spending in Canada by therapy 2017
- Eligible men for androgen replacement therapy in the United States 2001-2011
- Investment value in automotive finance industry in China 2013-2018
- Restricted access to finance affecting growth of mid-market companies UK 2015
- Distribution of vehicle loans in the U.S. 2019, by lender type
- Distribution of Taiwan's overseas credit guarantees 2018 by industry
- Provision of green microloans in Romania in 2013
Related topics
About Statista
Statista offers dossiers and reports on over 170 industries. With Statista you are always able to make informed decisions and boost your work efficiency.
Internet & Telecommunications
- Social Media
- E-Commerce
- Online Video & Entertainment
- Advertising & Marketing
Consumer Goods & FMCG
- Alcoholic Beverages
- Cleaning Products
- Cosmetics & Personal Care
- Food & Nutrition
Retail & Trade
- Health & Hygiene
- International Trade
- Shopping Behavior
- Sports & Leisure
Travel, Tourism & Hospitality
- Business Travel
- Leisure Travel
- Accomodation
- Restaurants
Society
- Demographics
- Economy
- Education & Science
- Politics & Government
Transportation & Logistics
- Aviation
- Rail Transport
- Vehicles & Road Traffic
- Water Transport
Statista Accounts:
Access All Statistics. Starting from $708 / Year
Save statistic in .XLS format
You can only download this statistic as a Premium user.
Save statistic in .PNG format
You can only download this statistic as a Premium user.
Save statistic in .PDF format
You can only download this statistic as a Premium user.
Show source references
As a Premium user you get access to the detailed source references and background information about this statistic.
Show details about this statistic
As a Premium user you get access to background information and details about the release of this statistic.
Bookmark statistics
As soon as this statistic is updated, you will immediately be notified via e-mail.
Yes, save as favorite!
...and make my research life easier.
Change statistics options
You need at least a Premium Account to use this feature.
Exclusive Corporate feature
This feature is limited to our corporate solutions.
Please contact us to get started with full access to dossiers, forecasts, studies and international data.
Corporate Account
We use cookies to personalize contents and ads, offer social media features, and analyze access to our website. In your browser settings you can configure or disable this, respectively, and can delete any already placed cookies. For details, please see your browser’s Help section (by pressing F1). Please see our privacy statement for details about how we use data.